As a child, John suffered from severe asthma which limited his sporting opportunities. However, he more than compensated for this with his academic achievements, reading voraciously and developing an outstanding general knowledge. His debating experience at school stood him in good stead in his later professional life. For as long as he could remember, John O'Shea had the aspiration to become a doctor. Of Irish heritage, John migrated to Western Australia with his family at the age of 10. As a "New Australian", he completed his schooling in Perth and made the natural progression into the field of medicine following in the footsteps of his parents, Sean and Mary, who were both doctors. Mary was determined to become the first doctor in her family despite the many obstacles in her way. In those days it was unusual for a 'lady' to be so interested in her education, so her mother wasn't at all encouraging. This truth was exemplified by the fact that there were just two women in her class of one hundred medical students.
John captained the St Louis
On the patriarchal side, John had three uncles who were also doctors. Whether this interest in medicine in the O'Shea family is genetic or environmental, it has certainly lived on. Dr O'Shea's brother is a doctor and his son, Breffny is on track to carry on 'the family business'. Cardiology was only one of the specialties that caught his attention during his internship, but John felt fortunate that he went down this path. As the field of cardiology has evolved, it has become more procedural, allowing him to demonstrate his talents as a surgeon and physician. John and Terri, his wife of more than 30 years, had three children, Michael, Breffny and Camilla. In his spare time, John enjoyed spending time boating around Rottnest and the Swan River. From fear of being asked to perform at WA Cardiology functions, he was reluctant to divulge that he played guitar and would occasionally entertain family and friends with 'folk rock' numbers.
During his long career he touched the lives of so many in his various roles as physician, teacher, friend, colleague, mentor, researcher and tireless contributor to the CSANZ. John will be greatly missed.
The Society would like to thank Dr Graeme Dedman and other friends and colleagues for their contribution to this Obituary.
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The Australasian Cardiac Outcomes Registry is up and running! We're now at the stage of recruiting hospitals and clinics -public and private -who want to participate in this important initiative of CSANZ. Dates for visits to Tamworth, Toowoomba, Tasmania and Northern Territory are close to finalisation, and a follow-up 1-day visit to Western Australia is in the second week of July.
Contact us now using details below if you're interested or have questions!
If you want a site visit, please let us know as soon as you can.
Your involvement will contribute to a highquality Australasian database. The more data we have, the better the results. Regular reporting and feedback of de-identified results will enable hospitals and clinicians to benchmark performance against national results, and shape healthcare delivery.
No fee is charged for participation for at least the first 12 months, and any future fee -if necessary at all -will be quantified in consultation with participating clinicians and sites.
We've designed registry processes with two overriding principles:
1. ensuring data privacy, while providing you with protected access to your own data; and 2. minimising resources required at sites for data collection These two principles have also guided the Steering Committee in much of its decisionmaking.
Our team is ready to support you at every step of the enrolment process. To get the ball rolling, contact us and ask for the ACOR Registry information package; it includes a Client Services Agreement that you'll need to start your participation.
Sites representing each Australian state in addition to New Zealand have already expressed interest and are in varied stages of enrolment. We are keen to hear from more of you. 
So sign up!

CONDITIONS:
 The R T Hall Prize will be awarded to an individual investigator for a coherent body of work, which advances knowledge of the cardiovascular system and its diseases. In exceptional circumstances, the Prize may be awarded to a small group for an outstanding contribution in the field of cardiology. The work must have been published in a scientific journal or journals. Work published in bookform and thesis, which have been accepted for higher degrees, may also be submitted.
 The investigator MUST be a Member of The CSANZ and the work must have been substantially undertaken in Australia or New Zealand.
 Submissions for the R T Hall Prize will consist of a nominating letter by a Member of The Society plus copies of the published manuscript(s), as well as, confirmation from the nominee(s) that they wish to be considered for the Prize.
 The R T Hall Prize will be decided by the Board after review by the Scientific Committee.
 The winner of the R T Hall Prize will be announced at the Annual General Meeting of The Society.
 The value of the R T Hall Prize will be $10,000. My opportunity to attend the American College of Cardiology's 64 th annual scientific session was one of the year's major highlights for me. I joined over 13,000 cardiologists from all over the world to take part in a venture that did not actually resemble a didactic "conference", but was characterised by interactive education and research where the audience members contributed as much to the event as the presenters. I was given the chance to discuss and compare different approaches to cardiovascular care from different countries and invited to consider the reasoning behind contemporary guidelines. Sometimes I think that junior doctors in Australia's hospital system practice "consultant-based-medicine" rather than "evidence-based-medicine", so being challenged by world experts as to whether I agree or disagree with their reasoning was an eye-opener for me.
Another aspect of the conference that showcased global teamwork were the poster sessions. Over 1,000 posters were presented, and authors ranged from medical students to professors of every gender and ethnicity. I personally presented a poster on costeffectiveness of strategies for preventing cardiotoxicity from chemotherapy. Contemporary physicians have been privileged with an incredible degree of autonomy in non-medical fields ranging from human resources, education, administration and health economics, and as such I believe there now exists an obligation for doctors to produce research in these fields to prove their responsible stewardship. I am not too modest to say that one cardiologist who chairs committees on ACC/AHA guidelines told me that my poster would influence how he practised cardiology.
As I left San Diego, my closing thoughts were that the ACC conference showcased the admirable ethos of cardiologists, particularly our desire to create a global-teamwork approach where there is a "knowledge migration" amongst nations, and opportunities to contribute are not limited by job description or country.
I would like to thank CSANZ and Amgen Australia for the opportunity to attend this event, as it wouldn't have happened without their generous assistance.
Mark Nolan Menzies Research Institute
University of Tasmania Royal Hobart Hospital 1. At the time of application, applicants must be current financial FCSANZ, Associate Members or Affiliate Members of the Cardiac Society, with preference given to early career applicants attending their first meeting.
2. The work must have emanated from Australia or New Zealand.
3. Applicants must have an abstract on a topic relevant to Heart Failure, accepted for presentation.
4. Applications must be accompanied by a letter from the supervisor or Director of the laboratory or service from which the work has emanated, clearly detailing the specific contribution made by the applicant towards the work being presented.
5. Preference will be given to those who have not previously been awarded a CSANZ Travelling Scholarship.
6. Conditions apply to successful applicants not domiciled in Australia or New Zealand.* 7. Late applications will NOT be considered.
8. The Scholarship is valued at $3,000
9. Successful recipient must agree to present in the next CSANZ Heart Failure Council Programme during the CSANZ Annual Scientific Meeting:
i. A summary of the highlights of the meeting and an overview of the top 5 Heart Failure papers they attended at the Heart Failure Society of America Meeting
ii. An oral presentation of their abstract.
10. Successful recipient to email the Heart F a i l u r e C o u n c i l S e c r e t a r y a t info@csanz.edu.au confirming availability to present in the next CSANZ Heart Failure Council Programme (See item 9). Please contact the Cardiac Society of Australia and New Zealand (CSANZ) and inform us of your name, contact details and the title of your research project.
Value: Up to a maximum of $70,000. The scholarship may be shared at the discretion of the Board.
Contact Christine Boyle, CSANZ, for more information on info@csanz.edu.au
Expressions of interest close 15 July 2015.
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Travelling Fellowship Update
I write to express my sincerest thanks to the CSANZ and Amgen Australia for awarding me a Travelling Fellowship to the 2015 American College of Cardiology Scientific Sessions. The opportunity to attend this world-class cardiology meeting and present my research was an exciting one.
I presented " Prediction of coronary artery disease extent and severity using Pulse Wave Velocity", research that was undertaken at Westmead Hospital. We found that In symptomatic individuals presenting for the investigation of suspected ischemia PWV does not predict the severity of obstructive coronary disease but instead predicts the overall burden of coronary plaque (obstructive and nonobstructive). This positive correlation between PWV and Extent score suggests that PWV may be predictive of future cardiovascular events due to the established link between Extent score and cardiovascular risk. The presence of diffuse coronary atheroma may be the pathophysiological link between the observed relationship between increased PWV and increased cardiovascular risk.
The meeting was a forum to learn about the latest trends in clinical cardiology as well as some new ideas and approaches for future risk stratification and management of coronary disease. In particular, there is an increasing interest and investment in women's heart disease, an essential future direction and one I have a significant interest in. The purpose of the clinics is to identify young Timorese patients with disease amenable to surgical intervention, which is unavailable locally.
Joseph
A wide range of pathology, particularly rheumatic heart disease, is seen.
A small charity has been founded (East Timor Hearts Fund) to provide the necessary financial support for surgical intervention.
This has been predominantly mitral balloon valvuloplasties, but also a significant amount of open heart surgery, including valve repairs and replacements. Whilst Dr Bayley hopes to continue to work for quite some years yet, the increased financial support that has become available means that support from an additional Cardiologist would be very welcome.
The work is interesting and challenging (particularly integrating best possible patient care with the various social, geographical and logistical challenges that East Timor presents).
Anyone interested in participating could email Dr Bayley on noelbayley@me.com or phone 0408 529 640. 
Probono Cardiology in East Timor
The Awards:
 The Awards are valued at $1,000 each to assist in defraying the costs of travel, accommodation etc with up to five being awarded.
 There will be up to three Awards to nursing and up to two to non-nursing applicants.
 Preference will be given on an equal basis to: a first time applicants for a CDA;
b applicants who have not previously attended a CSANZ conference;
 Should the recipient of a CDA subsequently be awarded a CSANZ ASM Travelling Fellowship in the same year, the recipient may choose which award they wish to have, but are only entitled to one award. 
